Cargando…

Screening of Cytotoxicity and Anti-Inflammatory Properties of Feijoa Extracts Using Genetically Modified Cell Models Targeting TLR2, TLR4 and NOD2 Pathways, and the Implication for Inflammatory Bowel Disease

Feijoa has been increasingly studied in the recent decade, while investigations into its bioactivities including anti-inflammatory activity are lacking. In this article, the cytotoxicity and anti-inflammatory properties of feijoa extracts, from flesh, peel and whole fruit, from four cultivars namely...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yaoyao, Bishop, Karen Suzanne, Ferguson, Lynnette Robin, Quek, Siew Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164462/
https://www.ncbi.nlm.nih.gov/pubmed/30200338
http://dx.doi.org/10.3390/nu10091188
_version_ 1783359606038200320
author Peng, Yaoyao
Bishop, Karen Suzanne
Ferguson, Lynnette Robin
Quek, Siew Young
author_facet Peng, Yaoyao
Bishop, Karen Suzanne
Ferguson, Lynnette Robin
Quek, Siew Young
author_sort Peng, Yaoyao
collection PubMed
description Feijoa has been increasingly studied in the recent decade, while investigations into its bioactivities including anti-inflammatory activity are lacking. In this article, the cytotoxicity and anti-inflammatory properties of feijoa extracts, from flesh, peel and whole fruit, from four cultivars namely APOLLO, UNIQUE, OPAL STAR and WIKI TU are presented. Three inflammatory pathways, Toll-like receptor 2 (TLR2), TLR4 and nucleotide-binding oligomerization domain-containing protein 2 (NOD2), were investigated using genetically modified cell models namely HEK-Blue™ hTLR2, HEK-Blue™ hTLR4, NOD2-WT and NOD2-G908R. Results show that feijoa peel extract induced higher cytotoxicity than flesh and whole fruit extracts, and the APOLLO cultivar was the most anti-inflammatory among the four tested cultivars. The anti-inflammatory activity of feijoa flesh was detected only through the TLR2 pathway, and the activity of feijoa peel and whole fruit was evident mainly through the TLR2 and NOD2 pathways. Most notably, feijoa anti-inflammatory activity was superior to ibuprofen particularly through the TLR2 pathway, with significantly lower secreted embryonic alkaline phosphatase IC50 concentrations (7.88, 12.81, 30.84 and 442.90 μg/mL for APOLLO flesh, peel, whole fruit extract and ibuprofen respectively). These findings indicate that feijoa has great potential to be used in the treatment and prevention of inflammation-related diseases including inflammatory bowel disease.
format Online
Article
Text
id pubmed-6164462
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61644622018-10-10 Screening of Cytotoxicity and Anti-Inflammatory Properties of Feijoa Extracts Using Genetically Modified Cell Models Targeting TLR2, TLR4 and NOD2 Pathways, and the Implication for Inflammatory Bowel Disease Peng, Yaoyao Bishop, Karen Suzanne Ferguson, Lynnette Robin Quek, Siew Young Nutrients Article Feijoa has been increasingly studied in the recent decade, while investigations into its bioactivities including anti-inflammatory activity are lacking. In this article, the cytotoxicity and anti-inflammatory properties of feijoa extracts, from flesh, peel and whole fruit, from four cultivars namely APOLLO, UNIQUE, OPAL STAR and WIKI TU are presented. Three inflammatory pathways, Toll-like receptor 2 (TLR2), TLR4 and nucleotide-binding oligomerization domain-containing protein 2 (NOD2), were investigated using genetically modified cell models namely HEK-Blue™ hTLR2, HEK-Blue™ hTLR4, NOD2-WT and NOD2-G908R. Results show that feijoa peel extract induced higher cytotoxicity than flesh and whole fruit extracts, and the APOLLO cultivar was the most anti-inflammatory among the four tested cultivars. The anti-inflammatory activity of feijoa flesh was detected only through the TLR2 pathway, and the activity of feijoa peel and whole fruit was evident mainly through the TLR2 and NOD2 pathways. Most notably, feijoa anti-inflammatory activity was superior to ibuprofen particularly through the TLR2 pathway, with significantly lower secreted embryonic alkaline phosphatase IC50 concentrations (7.88, 12.81, 30.84 and 442.90 μg/mL for APOLLO flesh, peel, whole fruit extract and ibuprofen respectively). These findings indicate that feijoa has great potential to be used in the treatment and prevention of inflammation-related diseases including inflammatory bowel disease. MDPI 2018-08-31 /pmc/articles/PMC6164462/ /pubmed/30200338 http://dx.doi.org/10.3390/nu10091188 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Peng, Yaoyao
Bishop, Karen Suzanne
Ferguson, Lynnette Robin
Quek, Siew Young
Screening of Cytotoxicity and Anti-Inflammatory Properties of Feijoa Extracts Using Genetically Modified Cell Models Targeting TLR2, TLR4 and NOD2 Pathways, and the Implication for Inflammatory Bowel Disease
title Screening of Cytotoxicity and Anti-Inflammatory Properties of Feijoa Extracts Using Genetically Modified Cell Models Targeting TLR2, TLR4 and NOD2 Pathways, and the Implication for Inflammatory Bowel Disease
title_full Screening of Cytotoxicity and Anti-Inflammatory Properties of Feijoa Extracts Using Genetically Modified Cell Models Targeting TLR2, TLR4 and NOD2 Pathways, and the Implication for Inflammatory Bowel Disease
title_fullStr Screening of Cytotoxicity and Anti-Inflammatory Properties of Feijoa Extracts Using Genetically Modified Cell Models Targeting TLR2, TLR4 and NOD2 Pathways, and the Implication for Inflammatory Bowel Disease
title_full_unstemmed Screening of Cytotoxicity and Anti-Inflammatory Properties of Feijoa Extracts Using Genetically Modified Cell Models Targeting TLR2, TLR4 and NOD2 Pathways, and the Implication for Inflammatory Bowel Disease
title_short Screening of Cytotoxicity and Anti-Inflammatory Properties of Feijoa Extracts Using Genetically Modified Cell Models Targeting TLR2, TLR4 and NOD2 Pathways, and the Implication for Inflammatory Bowel Disease
title_sort screening of cytotoxicity and anti-inflammatory properties of feijoa extracts using genetically modified cell models targeting tlr2, tlr4 and nod2 pathways, and the implication for inflammatory bowel disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164462/
https://www.ncbi.nlm.nih.gov/pubmed/30200338
http://dx.doi.org/10.3390/nu10091188
work_keys_str_mv AT pengyaoyao screeningofcytotoxicityandantiinflammatorypropertiesoffeijoaextractsusinggeneticallymodifiedcellmodelstargetingtlr2tlr4andnod2pathwaysandtheimplicationforinflammatoryboweldisease
AT bishopkarensuzanne screeningofcytotoxicityandantiinflammatorypropertiesoffeijoaextractsusinggeneticallymodifiedcellmodelstargetingtlr2tlr4andnod2pathwaysandtheimplicationforinflammatoryboweldisease
AT fergusonlynnetterobin screeningofcytotoxicityandantiinflammatorypropertiesoffeijoaextractsusinggeneticallymodifiedcellmodelstargetingtlr2tlr4andnod2pathwaysandtheimplicationforinflammatoryboweldisease
AT queksiewyoung screeningofcytotoxicityandantiinflammatorypropertiesoffeijoaextractsusinggeneticallymodifiedcellmodelstargetingtlr2tlr4andnod2pathwaysandtheimplicationforinflammatoryboweldisease